Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.88 billion. The enterprise value is $1.69 billion.
| Market Cap | 1.88B |
| Enterprise Value | 1.69B |
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 78.33 million shares outstanding. The number of shares has decreased by -4.10% in one year.
| Current Share Class | 78.33M |
| Shares Outstanding | 78.33M |
| Shares Change (YoY) | -4.10% |
| Shares Change (QoQ) | -5.26% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 102.64% |
| Float | 71.69M |
Valuation Ratios
The trailing PE ratio is 31.47 and the forward PE ratio is 11.50. Progyny's PEG ratio is 1.09.
| PE Ratio | 31.47 |
| Forward PE | 11.50 |
| PS Ratio | 1.46 |
| Forward PS | 1.30 |
| PB Ratio | 4.25 |
| P/TBV Ratio | 4.56 |
| P/FCF Ratio | 10.22 |
| P/OCF Ratio | 9.13 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.40, with an EV/FCF ratio of 9.14.
| EV / Earnings | 24.91 |
| EV / Sales | 1.30 |
| EV / EBITDA | 15.40 |
| EV / EBIT | 16.18 |
| EV / FCF | 9.14 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.13 |
| Quick Ratio | 2.07 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.24 |
| Debt / FCF | 0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.93% and return on invested capital (ROIC) is 28.06%.
| Return on Equity (ROE) | 14.93% |
| Return on Assets (ROA) | 9.12% |
| Return on Invested Capital (ROIC) | 28.06% |
| Return on Capital Employed (ROCE) | 22.52% |
| Weighted Average Cost of Capital (WACC) | 9.14% |
| Revenue Per Employee | $1.51M |
| Profits Per Employee | $79,081 |
| Employee Count | 856 |
| Asset Turnover | 1.81 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $38.09 million in taxes.
| Income Tax | 38.09M |
| Effective Tax Rate | 36.00% |
Stock Price Statistics
The stock price has increased by +7.85% in the last 52 weeks. The beta is 0.91, so Progyny's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +7.85% |
| 50-Day Moving Average | 18.56 |
| 200-Day Moving Average | 21.78 |
| Relative Strength Index (RSI) | 73.88 |
| Average Volume (20 Days) | 1,683,862 |
Short Selling Information
The latest short interest is 6.31 million, so 8.05% of the outstanding shares have been sold short.
| Short Interest | 6.31M |
| Short Previous Month | 5.53M |
| Short % of Shares Out | 8.05% |
| Short % of Float | 8.80% |
| Short Ratio (days to cover) | 4.97 |
Income Statement
In the last 12 months, Progyny had revenue of $1.29 billion and earned $67.69 million in profits. Earnings per share was $0.76.
| Revenue | 1.29B |
| Gross Profit | 311.76M |
| Operating Income | 104.19M |
| Pretax Income | 105.78M |
| Net Income | 67.69M |
| EBITDA | 109.51M |
| EBIT | 104.19M |
| Earnings Per Share (EPS) | $0.76 |
Balance Sheet
The company has $225.11 million in cash and $27.28 million in debt, with a net cash position of $197.83 million or $2.53 per share.
| Cash & Cash Equivalents | 225.11M |
| Total Debt | 27.28M |
| Net Cash | 197.83M |
| Net Cash Per Share | $2.53 |
| Equity (Book Value) | 439.34M |
| Book Value Per Share | 5.66 |
| Working Capital | 265.81M |
Cash Flow
In the last 12 months, operating cash flow was $206.33 million and capital expenditures -$21.91 million, giving a free cash flow of $184.42 million.
| Operating Cash Flow | 206.33M |
| Capital Expenditures | -21.91M |
| Depreciation & Amortization | 5.32M |
| Net Borrowing | n/a |
| Free Cash Flow | 184.42M |
| FCF Per Share | $2.35 |
Margins
Gross margin is 24.11%, with operating and profit margins of 8.06% and 5.23%.
| Gross Margin | 24.11% |
| Operating Margin | 8.06% |
| Pretax Margin | 8.18% |
| Profit Margin | 5.23% |
| EBITDA Margin | 8.47% |
| EBIT Margin | 8.06% |
| FCF Margin | 14.26% |
Dividends & Yields
Progyny does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.10% |
| Shareholder Yield | 4.10% |
| Earnings Yield | 3.59% |
| FCF Yield | 9.79% |
Analyst Forecast
The average price target for Progyny is $28.55, which is 18.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $28.55 |
| Price Target Difference | 18.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.70% |
| EPS Growth Forecast (5Y) | 20.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Progyny has an Altman Z-Score of 7.68 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.68 |
| Piotroski F-Score | 6 |